Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Salpingectomy at Time of Cesarean Delivery

Contraception; ePub 2018 Jun 20; Lehn, et al

As interest in total salpingectomy for permanent contraception at the time of cesarean delivery (CD) increases, surgeons should counsel patients that adhesions and proximity to large vessels may preclude completion of bilateral tubal removal, especially in women who have had multiple prior CDs. This according to a retrospective study of women who had a permanent contraception procedure during CD from November 2015 through April 2017. Among the details:

  • 122 women who underwent CD with planned concurrent permanent contraception procedure were identified.
  • 32 (26.2%) women preferred partial salpingectomy and 90 (73.8%) preferred total salpingectomy.
  • All women who desired partial salpingectomy had the procedure performed.
  • However, 17 (18.9%) women desiring total salpingectomy could not have the procedure performed bilaterally.
  • Among women who planned a total salpingectomy, having ≥3 CDs was the only factor associated with needing an alternative procedure.

Citation:

Lehn K, Gu L, Creinin MD, Chen MJ. Successful completion of total and partial salpingectomy at the time of cesarean delivery. [Published online ahead of print June 20, 2018]. Contraception. doi:10.1016/j.contraception.2018.06.003.

This Week's Must Reads

Prophylactic Antibiotic Use in Labor & Delivery, Obstet Gynecol; 2018 Sep; Coleman, et al

USPSTF on Screening for Cervical Cancer, JAMA; 2018 Aug 21; US Preventive Services Task Force

Prevention of Obstetric Lacerations at Vaginal Delivery, Obstet Gynecol; 2018 Sep; Cichowski, et al

Effect of Menstrual Bleeding on IUD Discontinuation, Am J Obstet Gynecol; ePub 2018 Aug 28; Hobby, et al

Leukemia risk after maternal contraception use, Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0

Must Reads in Contraception

Effect of Menstrual Bleeding on IUD Discontinuation, Am J Obstet Gynecol; ePub 2018 Aug 28; Hobby, et al

Leukemia risk after maternal contraception use, Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0

LARC in Women Treated for Opioid Use Disorder, Contraception; ePub 2018 Aug 13; Kotha, et al

Pregnancy Scares & Change in Contraceptive Use, Contraception; ePub 2018 Jul 26; Gatny, et al

Low Social Support & Undesired Pregnancy , Contraception; ePub 2018 Jul 2; Moseson, et al